BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23262279)

  • 21. Monitoring β-arrestin recruitment via β-lactamase enzyme fragment complementation: purification of peptide E as a low-affinity ligand for mammalian bombesin receptors.
    Ikeda Y; Kumagai H; Okazaki H; Fujishiro M; Motozawa Y; Nomura S; Takeda N; Toko H; Takimoto E; Akazawa H; Morita H; Suzuki J; Yamazaki T; Komuro I; Yanagisawa M
    PLoS One; 2015; 10(6):e0127445. PubMed ID: 26030739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1.
    van der Lee MM; Blomenröhr M; van der Doelen AA; Wat JW; Smits N; Hanson BJ; van Koppen CJ; Zaman GJ
    J Biomol Screen; 2009 Aug; 14(7):811-23. PubMed ID: 19520790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of structurally novel G protein biased CB
    Ford BM; Franks LN; Tai S; Fantegrossi WE; Stahl EL; Berquist MD; Cabanlong CV; Wilson CD; Penthala NR; Crooks PA; Prather PL
    Pharmacol Res; 2017 Nov; 125(Pt B):161-177. PubMed ID: 28838808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kappa opioid receptor screen with the Tango beta-arrestin recruitment technology and characterization of hits with second-messenger assays.
    Doucette C; Vedvik K; Koepnick E; Bergsma A; Thomson B; Turek-Etienne TC
    J Biomol Screen; 2009 Apr; 14(4):381-94. PubMed ID: 19403921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
    Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
    J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of 4-(phenyl)thio-1H-pyrazole derivatives as agonists of GPR109A, a high affinity niacin receptor.
    Kim HY; Jadhav VB; Jeong DY; Park WK; Song JH; Lee S; Cho H
    Arch Pharm Res; 2015 Jun; 38(6):1019-32. PubMed ID: 25599616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.
    Kotsikorou E; Madrigal KE; Hurst DP; Sharir H; Lynch DL; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak L; Abood ME; Reggio PH
    Biochemistry; 2011 Jun; 50(25):5633-47. PubMed ID: 21534610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of selective agonists and positive allosteric modulators for µ- and δ-opioid receptors from a single high-throughput screen.
    Burford NT; Wehrman T; Bassoni D; O'Connell J; Banks M; Zhang L; Alt A
    J Biomol Screen; 2014 Oct; 19(9):1255-65. PubMed ID: 25047277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring G protein-coupled receptor activation using an adenovirus-based β-arrestin bimolecular fluorescence complementation assay.
    Song YB; Park CO; Jeong JY; Huh WK
    Anal Biochem; 2014 Mar; 449():32-41. PubMed ID: 24361713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify receptor-transducer coupling and mediate intracellular pathway bias.
    Schihada H; Klompstra TM; Humphrys LJ; Cervenka I; Dadvar S; Kolb P; Ruas JL; Schulte G
    J Biol Chem; 2022 Sep; 298(9):102328. PubMed ID: 35933013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel functionally selective κ-opioid receptor scaffolds.
    White KL; Scopton AP; Rives ML; Bikbulatov RV; Polepally PR; Brown PJ; Kenakin T; Javitch JA; Zjawiony JK; Roth BL
    Mol Pharmacol; 2014 Jan; 85(1):83-90. PubMed ID: 24113749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.
    Allen JA; Yost JM; Setola V; Chen X; Sassano MF; Chen M; Peterson S; Yadav PN; Huang XP; Feng B; Jensen NH; Che X; Bai X; Frye SV; Wetsel WC; Caron MG; Javitch JA; Roth BL; Jin J
    Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18488-93. PubMed ID: 22025698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-arrestin mediates desensitization and internalization but does not affect dephosphorylation of the thyrotropin-releasing hormone receptor.
    Jones BW; Hinkle PM
    J Biol Chem; 2005 Nov; 280(46):38346-54. PubMed ID: 16183993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The BRET2/arrestin assay in stable recombinant cells: a platform to screen for compounds that interact with G protein-coupled receptors (GPCRS).
    Bertrand L; Parent S; Caron M; Legault M; Joly E; Angers S; Bouvier M; Brown M; Houle B; Ménard L
    J Recept Signal Transduct Res; 2002; 22(1-4):533-41. PubMed ID: 12503639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunter beta-arrestin assay.
    McGuinness D; Malikzay A; Visconti R; Lin K; Bayne M; Monsma F; Lunn CA
    J Biomol Screen; 2009 Jan; 14(1):49-58. PubMed ID: 19171920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular Assay to Study β-Arrestin Recruitment by the Cannabinoid Receptors 1 and 2.
    Bouma J; Soethoudt M; van Gils N; Xia L; van der Stelt M; Heitman LH
    Methods Mol Biol; 2023; 2576():189-199. PubMed ID: 36152187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a novel GPR35 agonist with high and equipotent species potency for oral treatment of IBD.
    Song Z; Lu D; Sun J; Ye Y; Fang J; Wang K; Guo S; Zhang Q; He X; Xie X; Shen J
    Bioorg Med Chem; 2023 Dec; 96():117511. PubMed ID: 37976806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visualizing differences in ligand-induced beta-arrestin-GFP interactions and trafficking between three recently characterized G protein-coupled receptors.
    Evans NA; Groarke DA; Warrack J; Greenwood CJ; Dodgson K; Milligan G; Wilson S
    J Neurochem; 2001 Apr; 77(2):476-85. PubMed ID: 11299310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay.
    Yin H; Chu A; Li W; Wang B; Shelton F; Otero F; Nguyen DG; Caldwell JS; Chen YA
    J Biol Chem; 2009 May; 284(18):12328-38. PubMed ID: 19286662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biased signaling at chemokine receptors.
    Corbisier J; Galès C; Huszagh A; Parmentier M; Springael JY
    J Biol Chem; 2015 Apr; 290(15):9542-54. PubMed ID: 25614627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.